Time filter

Source Type

Granada, Spain

Parada-Castellano R.,Instituto Cartuja
Color Research and Application | Year: 2016

The purpose of this research is to analyze the factors that create a sensation of balance or unbalance when a color image is observed depending on the light transmitted, reflected, and/or emitted by the objects that appear in it. This study is carried out by calculating the center of gravity (CG) of each image. The weight and the CG are obtained by calculating the force resulting from the different visual weights that make up the visual image and its position on this. When the visual CG and the geometric center coincide, it is recognized that the image is balanced. The action that acts on the balance of the lightness of an image is labeled as the visual weight. The visual weight of a figure is defined from the amount of visible light coming from it and the space occupied by this in the visual image. The colors show us the amount of light coming from a figure, while the shape provides us with information about the space that it occupies. The study explores how the qualities of appearance of three-dimensional objects affect visual weight and how it can vary due to changes in light, motion of objects or the perspective of the image. Since these calculations can be very complex, we have developed the software called "PesoVisual" that automatically performs these operations on digital color images. Similarly, this software enables the analysis of the variability of the visual image. © 2015 Wiley Periodicals, Inc.

Millan Cantero H.,Instituto Cartuja | Suarez Ramos J.,Instituto Cartuja | Garcia Laffitte E.,Instituto Cartuja | Gomez Gonzalez E.,University of Seville
Progresos de Obstetricia y Ginecologia | Year: 2011

Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a non-invasive surgical technique based on thermal coagulative necrosis of tissue by focused ultrasound guided by magnetic resonance. This fairly recent technique was approved by the American Food and Drug Administration in 2004 and by the European Union in 2006 for the treatment of uterine fibroids. In 2010 MRgFUS was approved by the European Union (CE label) for the treatment of adenomyosis and is being developed for the non-invasive treatment of other tumoral diseases, mainly in oncology. We present the first three cases of pregnancy achieved at the Instituto Cartuja, the only site in Spain with MRgFUS technology. We conclude that MRgFUS is a safe, reliable and effective technique for the treatment of uterine fibroids, even in women with a desire to preserve fertility. © 2011 SEGO.

Discover hidden collaborations